Octarine Bio ApS - CVR: 39857316

2023, DKK

17.06.2024

Bruttoresultat

1.089'

Primær drift

Na.

Årets resultat

-19.292'

Aktiver

34.789'

Kortfristede aktiver

32.593'

Egenkapital

-22.437'

Afkastningsgrad

0 %

Soliditetsgrad

-64 %

Likviditetsgrad

61 %

Resultat

17.06.2024

Årsrapport	2023 17.06.2024	2022 20.06.2023	2021 21.06.2022	2020 12.05.2021	2018 21.08.2020
Nettoomsætning
Bruttoresultat	1.089.445	1.378.113	1.681.548	916.667	0
Resultat af primær drift	0	0	0	0	0
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0
Finansielle indtægter	221.403	0	0	267.042	4.419
Finansieringsomkostninger	-2.207.228	-926.861	-308.053	-236.815	-2.553
Andre finansielle omkostninger	0	0	0	0	0
Resultat før skat	0	0	0	0	0
Resultat	-19.292.175	-9.671.375	-6.418.626	-2.372.514	-428.955
Forslag til udbytte	0	0	0	0	0

Aktiver

17.06.2024

Årsrapport	2023 17.06.2024	2022 20.06.2023	2021 21.06.2022	2020 12.05.2021	2018 21.08.2020
Kortfristede varebeholdninger	0	0	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	12.536.981	3.331.234	2.544.706	1.153.539	146.501
Likvider	20.055.703	9.285.855	10.950.275	6.205.680	177.865
Kortfristede aktiver	32.592.684	12.617.089	13.494.981	7.359.219	324.366
Immaterielle aktiver og goodwill	0	131.034	917.241	1.703.448	0
Finansielle anlægsaktiver	676.349	621.316	59.702	59.702	0
Materielle aktiver	1.520.451	1.970.613	204.010	209.151	0
Langfristede aktiver	2.196.800	2.722.963	1.180.953	1.972.301	0
Aktiver	34.789.484	15.340.052	14.675.934	9.331.520	324.366

Aktiver

17.06.2024

Passiver

17.06.2024

Årsrapport	2023 17.06.2024	2022 20.06.2023	2021 21.06.2022	2020 12.05.2021	2018 21.08.2020
Forslag til udbytte	0	0	0	0	0
Egenkapital	-22.437.015	-3.144.841	6.526.535	-900.219	-427.955
Hensatte forpligtelser	0	0	0	0	0
Langfristet gæld til banker	0	0	0	0	0
Anden langfristet gæld		0	0	0	4.494
Leverandører af varer og tjenesteydelser	981.160	762.252	926.722	194.510	199.416
Kortfristede forpligtelser	53.798.409	15.008.406	5.120.828	4.747.989	747.827
Gældsforpligtelser	57.226.499	18.484.893	8.149.399	10.231.739	752.321
Forpligtelser	57.226.499	18.484.893	8.149.399	10.231.739	752.321
Passiver	34.789.484	15.340.052	14.675.934	9.331.520	324.366

Passiver

17.06.2024

Nøgletal

17.06.2024

Årsrapport	2023 17.06.2024	2022 20.06.2023	2021 21.06.2022	2020 12.05.2021	2018 21.08.2020
Afkastningsgrad	Na.	Na.	Na.	Na.	Na.
Dækningsgrad	Na.	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	86,0 %	307,5 %	-98,3 %	263,5 %	100,2 %
Payout-ratio	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	Na.	Na.	Na.	Na.	Na.
Soliditestgrad	-64,5 %	-20,5 %	44,5 %	-9,6 %	-131,9 %
Likviditetsgrad	60,6 %	84,1 %	263,5 %	155,0 %	43,4 %

Resultat

17.06.2024

Gæld

17.06.2024

Årsrapport

17.06.2024

Nyeste:01.01.2023- 31.12.2023(offentliggjort: 17.06.2024)

Information om virksomhedens regnskabsklasse:The annual report of Octarine Bio ApS for 2023 has been prepared in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B and the Accounting Standard on small enterprises, as well as provisions applying to reporting class C entities. The accounting policies applied are consistent with those of last year. The annual report for 2023 is presented in DKK.

Beretning

17.06.2024

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:The Board of Directors and the Executive board have today discussed and approved the annual report of Octarine Bio ApS for the financial year 1 January - 31 December 2023.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Business review Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation and exploration. Octarine was founded in 2018, based on foundational research conducted at the at The University of Copenhagen and at The Technical University of Denmark. Grounded in a robust scientific foundation and unrivalled expertise in cell factory engineering, precision fermentation and enzymatic enhancement, we proudly unveil world-leading synthetic biology platforms, poised to transform entire industries for the betterment of society and the planet. Our core program focuses on developing a new class of bio-based colorants to improve the environmental footprint of the textiles industry. Textiles and clothing are an important multi-trillion industry with high levels of employment and a turnover of E162 billion in Europe. The industry is also a substantial contributor to employment in developing countries across the globe. Global demand for clothing is projected to increase significantly over the coming decade, as more than 8 billion people continue to consume increasing amounts of apparel. The wet processing (textile dyeing) stage is a hotspot for negative impacts on climate, human health and ecosystem quality, which highlights the urgent need for radical and sustainable colour solutions. Octarine produces a range of natural dyes in difficult to source colours with significantly reduced environmental impact, and further, through an innovative dyeing process, efficiently dyes a range of natural and synthetic fabrics directly without the use of mordants or other harmful chemical additives. During 2023, we have shown further progress throughout the R&D pipeline and were focused on OB-CLRTM - a new class of natural colors that are each vibrant, intensely colored molecules in highly sought after and difficult to source colors (purple, pink, dark blue, dark green). OB-CLRTM Octarine has swiftly generated major interest for the CLR program from many companies across industries. Our primary segment of interest is textiles for fashion, in particular clothing. Within this segment, we have had discussions with and introduced our technology to over 20 companies. Approximately half of these companies are globally leading fashion brands while others are leading dye houses/ garment producers across the globe. Outside of the textile and fabric industry, Octarine’s dye has the potential to be utilized in paints and inks (e. g., pens and digital printing), on non-textile materials, in cosmetics, and in food and beverage. We are in discussions with large companies within these industries as well and success with any of these players could result in a significant revenue upside for Octarine. Octarine is currently negotiating commercial terms under LoI with handful of selected commercial partners.